Related Experiment Videos
Mycosis fungoides: an Australian experience
A Yen1, A McMichael, M Kilkenny
1Department of Dermatology, University of Texas Medical Branch at Galveston, USA.
The Australasian Journal of Dermatology
|June 1, 1997
Summary
This study of 107 mycosis fungoides patients found disease presentation and initial treatments did not impact outcomes. Early diagnosis and treatment are crucial for managing this skin lymphoma.
Area of Science:
- Dermatology
- Oncology
- Epidemiology
Background:
- Mycosis fungoides is the most common type of cutaneous T-cell lymphoma.
- Understanding its clinical presentation and treatment patterns is essential for patient management.
Purpose of the Study:
- To analyze the clinical characteristics, treatment modalities, and outcomes of mycosis fungoides patients.
- To identify factors influencing disease progression and patient survival.
Main Methods:
- Retrospective analysis of 107 mycosis fungoides patients diagnosed between 1977 and 1995.
- Data collected included age at diagnosis, symptom onset, disease stage, residence, treatment history, and follow-up duration.
Main Results:
- The mean age at diagnosis was 55 years, significantly later than symptom onset (48 years).
- Urban residence was over-represented. Most patients (84%) were diagnosed at Stage I or II.
- Initial treatments included PUVA, topical steroids, or nitrogen mustard; stage at presentation did not correlate with treatment outcomes, recurrence, or survival.
Conclusions:
- Mycosis fungoides often presents at earlier stages, with urban residence being a common factor.
- Initial treatment choices and disease stage at presentation did not significantly affect long-term outcomes or survival in this cohort.